<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>162 氣管，支氣管及肺之惡性腫瘤</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>162-氣管，支氣管及肺之惡性腫瘤</caption>
<thead><tr><th>ICD 162</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>162</td><td>Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene)</td><td>10p11.23</td><td>MAP3K8, COT, EST, TPL2</td><td><a href="https://www.omim.org/entry/191195?search=191195" target="_blank">191195</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide</td><td>3q26.32</td><td>PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO</td><td><a href="https://www.omim.org/entry/171834?search=171834" target="_blank">171834</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Interferon regulatory factor-1</td><td>5q31.1</td><td>IRF1, MAR</td><td><a href="https://www.omim.org/entry/147575?search=147575" target="_blank">147575</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Protein phosphatase 2, structural/regulatory subunit A, beta</td><td>11q23.1</td><td>PPP2R1B</td><td><a href="https://www.omim.org/entry/603113?search=603113" target="_blank">603113</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Excision repair cross complementing rodent repair deficiency, complementation group 6</td><td>10q11.23</td><td>ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11</td><td><a href="https://www.omim.org/entry/609413?search=609413" target="_blank">609413</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Parkin</td><td>6q26</td><td>PRKN, PARK2, PDJ, LPRS2</td><td><a href="https://www.omim.org/entry/602544?search=602544" target="_blank">602544</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>RAS association domain family protein 1</td><td>3p21.31</td><td>RASSF1</td><td><a href="https://www.omim.org/entry/605082?search=605082" target="_blank">605082</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)</td><td>17q12</td><td>ERBB2, NGL, NEU, HER2</td><td><a href="https://www.omim.org/entry/164870?search=164870" target="_blank">164870</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)</td><td>11p15.4</td><td>SLC22A1L, BWSCR1A, IMPT1</td><td><a href="https://www.omim.org/entry/602631?search=602631" target="_blank">602631</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog</td><td>12p12.1</td><td>KRAS, KRAS2, RASK2, NS, CFC2, RALD</td><td><a href="https://www.omim.org/entry/190070?search=190070" target="_blank">190070</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Epidermal growth factor receptor</td><td>7p11.2</td><td>EGFR, NISBD2</td><td><a href="https://www.omim.org/entry/131550?search=131550" target="_blank">131550</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Fas ligand (TNF superfamily, member 6)</td><td>1q24.3</td><td>FASLG, TNFSF6, APT1LG1, FASL, ALPS1B</td><td><a href="https://www.omim.org/entry/134638?search=134638" target="_blank">134638</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Caspase 8, apoptosis-related cysteine protease</td><td>2q33.1</td><td>CASP8, MCH5, ALPS2B</td><td><a href="https://www.omim.org/entry/601763?search=601763" target="_blank">601763</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Deleted in lung and esophageal cancer 1</td><td>3p22.2</td><td>DLEC1, DLC1</td><td><a href="https://www.omim.org/entry/604050?search=604050" target="_blank">604050</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Murine sarcoma viral (v-raf) oncogene homolog B1</td><td>7q34</td><td>BRAF, NS7</td><td><a href="https://www.omim.org/entry/164757?search=164757" target="_blank">164757</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6</td><td>19q13.2</td><td>CYP2A6, CYP2A3, CYP2A, P450C2A</td><td><a href="https://www.omim.org/entry/122720?search=122720" target="_blank">122720</a></td><td><a href="https://www.omim.org/entry/211980?search=211980" target="_blank">211980</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Lung cancer 1</td><td>6q23-q25</td><td>LNCR1</td><td><a href="https://www.omim.org/entry/608935?search=608935" target="_blank">608935</a></td><td><a href="https://www.omim.org/entry/608935?search=608935" target="_blank">608935</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Dicer, Drosophila, homolog of, 1</td><td>14q32.13</td><td>DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW</td><td><a href="https://www.omim.org/entry/606241?search=606241" target="_blank">606241</a></td><td><a href="https://www.omim.org/entry/601200?search=601200" target="_blank">601200</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Lung cancer susceptibility 5</td><td>3q28</td><td>LNCR5</td><td><a href="https://www.omim.org/entry/614210?search=614210" target="_blank">614210</a></td><td><a href="https://www.omim.org/entry/614210?search=614210" target="_blank">614210</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>162</td><td>Lung cancer susceptibility 3</td><td>5p15.33</td><td>LNCR3</td><td><a href="https://www.omim.org/entry/612571?search=612571" target="_blank">612571</a></td><td><a href="https://www.omim.org/entry/612571?search=612571" target="_blank">612571</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>162</td><td>Lung cancer susceptibility 4</td><td>6p21.33</td><td>LNCR4</td><td><a href="https://www.omim.org/entry/612593?search=612593" target="_blank">612593</a></td><td><a href="https://www.omim.org/entry/612593?search=612593" target="_blank">612593</a></td><td>YES</td><td></td><td></td></tr>
</tbody></table>
</body>
</html>
